AKTX
Akari Therapeutics·NASDAQ
--
--(--)
--
--(--)
AKTX fundamentals
Akari Therapeutics (AKTX) released its earnings on Aug 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.08 (YoY --), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.08
--
Report date
Aug 13, 2025
Earnings Call
11:00 AM on Aug 18, 2025
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Akari Therapeutics (AKTX) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Akari Therapeutics (AKTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Akari Therapeutics (AKTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Akari Therapeutics (AKTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Akari Therapeutics (AKTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Akari Therapeutics (AKTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Akari Therapeutics's management provide for the next earnings period?What is the market's earnings forecast for Akari Therapeutics next quarter?What is Akari Therapeutics's latest dividend and current dividend yield?What factors drove the changes in Akari Therapeutics's revenue and profit?What were the key takeaways from Akari Therapeutics’s earnings call?What is the revenue and EPS growth rate for Akari Therapeutics year over year?What were the key takeaways from Akari Therapeutics's earnings call?What does Akari Therapeutics do and what are its main business segments?
